Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

South Korea flag South Korea · Delayed Price · Currency is KRW
85,500
+400 (0.47%)
Last updated: Jun 5, 2025
-16.49%
Market Cap 1.13T
Revenue (ttm) 1.63T
Net Income (ttm) 95.28B
Shares Out 13.18M
EPS (ttm) 7,211.39
PE Ratio 11.86
Forward PE 13.05
Dividend 1,100.00 (1.29%)
Ex-Dividend Date Dec 27, 2024
Volume 20,083
Average Volume 25,056
Open 85,100
Previous Close 85,100
Day's Range 84,600 - 85,900
52-Week Range 70,900 - 124,000
Beta 0.85
RSI 62.80
Earnings Date Jul 25, 2025

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair colo... [Read more]

Sector Healthcare
Founded 1941
Employees 2,276
Stock Exchange Korea Stock Exchange
Ticker Symbol 185750
Full Company Profile

Financial Performance

In 2024, KRX:185750's revenue was 1.59 trillion, a decrease of -4.97% compared to the previous year's 1.67 trillion. Earnings were 109.07 billion, a decrease of -48.68%.

Financial Statements

News

There is no news available yet.